Biodefense Global Industry Overview 2021-2030: AI and Machine Learning to Revolutionize Early Detection and Response
19. November 2024 07:39 ET
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Biodefense - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Biodefense market is estimated at...
U.S. Biodefense Industry Research 2024-2030: Focus on Anthrax, Small Pox, Botulism, & Radiation/Nuclear
24. Juli 2024 10:23 ET
|
Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "U.S. Biodefense Market Size, Share & Trends Analysis Report by Product (Anthrax, Small Pox, Botulism, Radiation/nuclear), and Segment Forecasts,...
Biodefense Industry Trends and Opportunities 2021-2025 - Insights Into Anthrax, Smallpox, Botulism, and Other Applications
07. Februar 2022 05:03 ET
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Biodefense Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The global biodefense market is projected to grow by...
Emergent BioSolutions Awarded 10-Year HHS Contract to Deliver ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) Into the Strategic National Stockpile
03. September 2019 06:30 ET
|
Emergent BioSolutions
Reaffirms ACAM2000 as a key component of the U.S. preparedness stance against the threat of smallpox as a biologic weaponSupports the government’s continued efforts and long-term strategy to maintain...
Aphios Is Developing Pathogen Inactivation Technology For Human Plasma Units
26. September 2018 08:00 ET
|
Aphios
WOBURN, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung...
PositiveID Subsidiary Chief Science Officer Delivers Co-Authored Report to U.S. Department of Defense on Agroterrorism Threat
08. Mai 2018 08:15 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., May 08, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSIDD), ExcitePCR subsidiary today announced publication of a report co-authored by its...
PositiveID Corporation to Present at the LD MICRO “Main Event” Investor Conference on December 2, 2015
18. November 2015 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 18, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company with an extensive patent portfolio, announced today...
PositiveID Corporation Issues Revenue Guidance of $3-6 Million for 2015
05. Februar 2015 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Feb. 5, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today issued...
PositiveID Corporation Prepares Additional M-BAND Systems for Field Deployment and Testing
20. Januar 2015 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Jan. 20, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...
PositiveID's M-BAND System Shipped to Korea for Testing to Protect U.S. Military
20. August 2014 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 20, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced...